by bmi_wpadmin | Dec 10, 2024 | BayMedica, Cannabinoids
Unlocking Innovation in Cannabinoids In the cannabis industry, unlocking the potential of rare cannabinoids is crucial to advancing innovation and meeting the rising demand for precision health and wellness products. Nature has gifted us with a remarkable...
by bmi_wpadmin | Sep 23, 2024 | BayMedica, Cannabinoids, CBC, Tetrahydrocannabivarin (THCV)
It is encouraging when ethical decisions also make financial sense. In the cannabis industry, utilizing sustainable bioidentical ingredients derived from the cannabis plant enables us to accomplish both goals. What does a more sustainable industry look like with minor...
by bmi_wpadmin | Sep 23, 2024 | BayMedica, Cannabinoids, Tetrahydrocannabivarin (THCV)
With the increasing demand for health and wellness products that tap into the natural benefits of cannabinoids, non-intoxicating THCV (Tetrahydrocannabivarin) is quickly becoming a standout ingredient for innovative CPG product developers. From metabolic health to...
by bmi_wpadmin | Sep 23, 2024 | BayMedica, Cannabidivarin (CBDV), Cannabinoids
Cannabidivarin, also known as CBDV, is a rare non-intoxicating cannabinoid first isolated in 1969. CBDV may share a similar name to its well-known cousin, cannabidiol, or CBD, but unlike CBD, CBDV is a minor cannabinoid and has demonstrated unique physiological...
by bmi_wpadmin | Jun 2, 2022 | BayMedica, Cannabinoids
As everyone in the cannabis and hemp industries knows, supply chain issues can be a major threat to business. The pandemic has unleashed chaos on supply chains across the globe, and the cannabis industry has not been spared. While the COVID-induced supply chain issues...
Recent Comments